| Entry |
|
|---|
| Name |
Alaproclate (USAN/INN) |
|---|
| Formula |
C13H18ClNO2
|
|---|
| Exact mass |
255.1026
|
|---|
| Mol weight |
255.7405
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01659 Selective serotonin reuptake inhibitor (SSRI)
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidepressant, Selective serotonin reuptake inhibitor (SSRI) |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06A ANTIDEPRESSANTS
N06AB Selective serotonin reuptake inhibitors
N06AB07 Alaproclate
D02787 Alaproclate (USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01659 Selective serotonin reuptake inhibitor (SSRI)
D02787 Alaproclate
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A4 (HTT)
D02787 Alaproclate (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C1c C 22.8902 -16.8700
2 N1a N 22.8902 -18.2701
3 C1a C 24.1026 -16.1700
4 C7a C 21.6778 -16.1700
5 O7a O 20.4652 -16.8700
6 C1d C 19.2528 -16.1700
7 C1b C 18.0404 -16.8700
8 C8y C 16.8279 -16.1700
9 C8x C 15.6155 -16.8700
10 O6a O 21.6778 -14.7700
11 C1a C 20.4652 -15.4700
12 C1a C 18.0404 -15.4700
13 C8x C 16.8279 -14.7700
14 C8x C 15.6155 -14.0700
15 C8y C 14.4031 -14.7700
16 C8x C 14.4031 -16.1700
17 X Cl 13.1906 -14.0700
BOND 17
1 1 3 1
2 1 4 1
3 4 5 1
4 5 6 1
5 6 7 1
6 7 8 1
7 8 9 2
8 1 2 1
9 4 10 2
10 6 11 1
11 6 12 1
12 8 13 1
13 13 14 2
14 14 15 1
15 15 16 2
16 9 16 1
17 15 17 1
|
|---|
